[1]
“High sensitivity versus low level of vancomycin needs to be concern for another alternative anti- Staphylococcus aureus as the first- line antibiotic”, Acta Biomed, vol. 90, no. 4, pp. 498–503, Dec. 2019, doi: 10.23750/abm.v90i4.7646.